文献速递疝与腹壁外科胃肠外科

机器人手术治疗腹股沟疝与腹壁疝:系统综述与Meta分析

Robotic surgery for inguinal and ventral hernia repair: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2023-11-20

该系统综述与Meta分析评估机器人手术对比腹腔镜或开放手术治疗腹股沟疝(IHR)与腹壁疝(VHR)的有效性,检索PubMed与EMBASE至2022年7月。共纳入64项研究,58项用于汇总分析:35项IHR研究(227 242例患者)与32项VHR研究(158 384例患者)。机器人IHR较腹腔镜IHR疝复发率更低(OR 0.54;95%CI 0.29, 0.99;I2: 0%),较开放IHR阿片类药物使用更少(OR 0.46;95%CI 0.25, 0.84;I2: 55.8%);机器人VHR较腹腔镜VHR肠损伤更少(OR 0.59;95%CI 0.42, 0.85;I2: 0%)且中转开放更少(OR 0.51;95%CI 0.43, 0.60;I2: 0%);机器人VHR较开放手术术后并发症更少(OR 0.61;95%CI 0.39, 0.96;I2: 68%)、手术部位感染更少(OR 0.47;95%CI 0.31, 0.72;I2: 0%)、术中出血更少(-95 mL)、住院时间更短(-3.4天)、再入院更少(OR 0.66;95%CI 0.44, 0.99;I2: 24.7%);但机器人IHR与VHR手术时间均较腹腔镜和开放手术显著更长。

要点

  • 机器人IHR较腹腔镜IHR疝复发率更低(OR 0.54;95%CI 0.29, 0.99;I2: 0%)。
  • 机器人VHR较腹腔镜VHR肠损伤更少(OR 0.59;95%CI 0.42, 0.85;I2: 0%)且中转开放更少(OR 0.51;95%CI 0.43, 0.60;I2: 0%)。
  • 机器人IHR与VHR手术时间均较腹腔镜和开放手术显著更长。

核心结论

  • 这些结果支持机器人手术作为IHR与VHR安全、有效且可行的替代方案,因其较腹腔镜和开放手术可带来多项术中与术后优势。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed与EMBASE至2022年7月。
  • 共纳入64项研究,58项用于汇总数据分析:35项IHR研究(227 242例患者)与32项VHR研究(158 384例患者)。

主要发现

  • 机器人IHR较腹腔镜IHR疝复发率更低(OR 0.54;95%CI 0.29, 0.99;I2: 0%)。
  • 机器人IHR较开放IHR阿片类药物使用更少(OR 0.46;95%CI 0.25, 0.84;I2: 55.8%)。
  • 机器人VHR较腹腔镜VHR肠损伤更少(OR 0.59;95%CI 0.42, 0.85;I2: 0%)且中转开放更少(OR 0.51;95%CI 0.43, 0.60;I2: 0%)。
  • 机器人VHR较开放手术术后并发症更少(OR 0.61;95%CI 0.39, 0.96;I2: 68%)、手术部位感染更少(OR 0.47;95%CI 0.31, 0.72;I2: 0%)、术中出血更少(-95 mL)、住院时间更短(-3.4天)、再入院更少(OR 0.66;95%CI 0.44, 0.99;I2: 24.7%)。
  • 机器人IHR与VHR手术时间均较腹腔镜和开放手术显著更长。

关键数值与推荐

  • 机器人IHR较腹腔镜IHR疝复发率OR 0.54(95%CI 0.29, 0.99;I2: 0%)。
  • 机器人IHR较开放IHR阿片类药物使用OR 0.46(95%CI 0.25, 0.84;I2: 55.8%)。
  • 机器人VHR较腹腔镜VHR肠损伤OR 0.59(95%CI 0.42, 0.85;I2: 0%)、中转开放OR 0.51(95%CI 0.43, 0.60;I2: 0%)。
  • 机器人VHR较开放手术术后并发症OR 0.61(95%CI 0.39, 0.96;I2: 68%)、手术部位感染OR 0.47(95%CI 0.31, 0.72;I2: 0%)、术中出血-95 mL、住院时间-3.4天、再入院OR 0.66(95%CI 0.44, 0.99;I2: 24.7%)。

临床怎么用

  • 作者认为机器人手术可作为IHR与VHR安全、有效且可行的替代方案,较腹腔镜和开放手术具有多项术中与术后优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This systematic review and meta-analysis assessed the effectiveness of robotic surgery compared to laparoscopy or open surgery for inguinal (IHR) and ventral (VHR) hernia repair. METHODS: PubMed and EMBASE were searched up to July 2022. Meta-analyses were performed for postoperative complications, surgical site infections (SSI), seroma/hematoma, hernia recurrence, operating time (OT), intraoperative blood loss, intraoperative bowel injury, conversion to open surgery, length of stay (LOS), mortality, reoperation rate, readmission rate, use of opioids, time to return to work and time to return to normal activities. RESULTS: Overall, 64 studies were selected and 58 were used for pooled data analyses: 35 studies (227 242 patients) deal with IHR and 32 (158 384 patients) with VHR. Robotic IHR was associated with lower hernia recurrence (OR 0.54; 95%CI 0.29, 0.99; I2: 0%) compared to laparoscopic IHR, and lower use of opioids compared to open IHR (OR 0.46; 95%CI 0.25, 0.84; I2: 55.8%). Robotic VHR was associated with lower bowel injuries (OR 0.59; 95%CI 0.42, 0.85; I2: 0%) and less conversions to open surgery (OR 0.51; 95%CI 0.43, 0.60; I2: 0%) compared to laparoscopy. Compared to open surgery, robotic VHR was associated with lower postoperative complications (OR 0.61; 95%CI 0.39, 0.96; I2: 68%), less SSI (OR 0.47; 95%CI 0.31, 0.72; I2: 0%), less intraoperative blood loss (- 95 mL), shorter LOS (- 3.4 day), and less hospital readmissions (OR 0.66; 95%CI 0.44, 0.99; I2: 24.7%). However, both robotic IHR and VHR were associated with significantly longer OT compared to laparoscopy and open surgery. CONCLUSION: These results support robotic surgery as a safe, effective, and viable alternative for IHR and VHR as it can brings several intraoperative and postoperative advantages over laparoscopy and open surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. de'Angelis N, Schena CA, Moszkowicz D, et al. Robotic surgery for inguinal and ventral hernia repair: a systematic review and meta-analysis. Surg Endosc. 2023. PMID: 37985490. doi:10.1007/s00464-023-10545-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。